$COLL
COLLEGIUM PHARMACEUTICAL, INC Stock $coll

$coll Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000155837024001526 Filed on February 22, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$144.9M	$149.7M	$566.8M
YoY Change	0.11%	15.53%	22.17%
Cost Of Revenue	$53.47M	$55.12M	$240.6M
YoY Change	-20.63%	-30.96%	-5.44%
Gross Profit	$91.46M	$94.63M	$326.2M
YoY Change	18.16%	90.06%	55.7%
Gross Profit Margin	63.11%	63.19%	57.55%
Selling, General & Admin	$41.98M	$32.94M	$159.2M
YoY Change	-20.45%	-13.38%	-7.54%
% of Gross Profit	45.9%	34.81%	48.81%
Research & Development		$0.00	$0.00
YoY Change			-100.0%
% of Gross Profit		0.0%	0.0%
Depreciation & Amortization	$917.0K	$35.46M	$3.496M
YoY Change	12.24%	-17.73%	30.25%
% of Gross Profit	1.0%	37.48%	1.07%
Operating Expenses	$41.98M	$32.94M	$159.2M
YoY Change	-20.45%	-13.38%	-9.63%
Operating Profit	$49.47M	$61.69M	$167.0M
YoY Change	100.89%	424.69%	401.1%
Interest Expense	$17.34M	$19.28M	$83.34M
YoY Change	-19.08%	-6.29%	31.84%
% of Operating Profit	35.05%	31.26%	49.92%
Other Income/Expense, Net
YoY Change
Pretax Income	$36.62M	$46.71M	$75.73M
YoY Change	-308.59%	-699.54%	-362.53%
Income Tax	$8.909M	$14.77M	$27.58M
% Of Pretax Income	24.33%	31.62%	36.41%
Net Earnings	$27.71M	$31.94M	$48.16M
YoY Change	-259.03%	-543.67%	-292.6%
Net Earnings / Revenue	19.12%	21.33%	8.5%
Basic Earnings Per Share	$0.86	$0.99	$1.43
Diluted Earnings Per Share	$0.71	$0.82	$1.29
COMMON SHARES
Basic Shares Outstanding	31.96M	32.61M	33.74M
Diluted Shares Outstanding	41.44M	41.28M	41.79M

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$318.0M	$315.3M	$310.5M
YoY Change	18.02%	81.52%	78.8%
Cash & Equivalents	$228.6M	$238.9M	$238.9M
Short-Term Investments	$89.44M	$76.33M	$71.60M
Other Short-Term Assets	$15.24M	$93.00K	$15.20M
YoY Change	-9.26%	63.16%	-8.91%
Inventory	$31.28M	$32.33M	$32.33M
Prepaid Expenses		$5.938M
Receivables	$174.7M	$179.5M	$179.5M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$539.3M	$537.6M	$537.6M
YoY Change	8.22%	28.0%	28.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$15.46M	$15.98M	$22.01M
YoY Change	-18.13%	-18.12%	-16.56%
Goodwill	$133.9M	$133.9M
YoY Change	0.0%	0.12%
Intangibles	$387.2M	$421.7M
YoY Change	-26.95%	-25.69%
Long-Term Investments
YoY Change
Other Assets	$954.0K	$825.0K	$28.13M
YoY Change	996.55%	725.0%	5.77%
Total Long-Term Assets	$575.0M	$605.7M	$605.7M
YoY Change	-19.69%	-19.68%	-19.68%
TOTAL ASSETS
Total Short-Term Assets	$539.3M	$537.6M	$537.6M
Total Long-Term Assets	$575.0M	$605.7M	$605.7M
Total Assets	$1.114B	$1.143B	$1.143B
YoY Change	-8.24%	-2.63%	-2.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.020M	$8.692M	$8.692M
YoY Change	101.2%	148.77%	148.77%
Accrued Expenses	$38.19M	$37.57M	$258.7M
YoY Change	56.3%	3.99%	-1.76%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$183.3M	$183.3M	$183.3M
YoY Change	0.0%	12.82%	12.82%
Total Short-Term Liabilities	$446.4M	$457.9M	$457.9M
YoY Change	8.17%	5.58%	5.58%
LONG-TERM LIABILITIES
Long-Term Debt	$439.8M	$483.8M	$483.8M
YoY Change	-28.49%	-10.14%	-10.14%
Other Long-Term Liabilities	$5.860M	$6.124M	$6.124M
YoY Change	-14.74%	-13.89%	-13.89%
Total Long-Term Liabilities	$445.6M	$490.0M	$490.0M
YoY Change	-28.34%	-10.19%	-10.19%
TOTAL LIABILITIES
Total Short-Term Liabilities	$446.4M	$457.9M	$457.9M
Total Long-Term Liabilities	$445.6M	$490.0M	$490.0M
Total Liabilities	$892.1M	$947.9M	$947.9M
YoY Change	-13.77%	-3.21%	-3.21%
SHAREHOLDERS EQUITY
Retained Earnings	-$205.5M	-$233.2M
YoY Change	-31.23%	-17.12%
Common Stock	$39.00K	$38.00K
YoY Change	2.63%	2.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$222.2M	$195.4M	$195.4M
YoY Change
Total Liabilities & Shareholders Equity	$1.114B	$1.143B	$1.143B
YoY Change	-8.24%	-2.63%	-2.63%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$27.71M	$31.94M	$48.16M
YoY Change	-259.03%	-543.67%	-292.6%
Depreciation, Depletion And Amortization	$917.0K	$35.46M	$3.496M
YoY Change	12.24%	-17.73%	30.25%
Cash From Operating Activities	$61.94M	$73.34M	$274.7M
YoY Change	123.83%	10.57%	121.16%
INVESTING ACTIVITIES
Capital Expenditures	$568.0K	$164.0K	$461.0K
YoY Change	222.73%	-82.55%	-71.58%
Acquisitions
YoY Change
Other Investing Activities	-$17.56M	-$24.93M	-$70.35M
YoY Change
Cash From Investing Activities	-$18.13M	-$25.10M	-$70.81M
YoY Change	10200.0%	2569.89%	-87.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$75.00M
YoY Change			433.31%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-54.15M	-67.83M	-140.2M
YoY Change	-179.28%	162.66%	-132.1%
NET CHANGE
Cash From Operating Activities	61.94M	73.34M	274.7M
Cash From Investing Activities	-18.13M	-25.10M	-70.81M
Cash From Financing Activities	-54.15M	-67.83M	-140.2M
Net Change In Cash	-10.34M	-19.58M	63.76M
YoY Change	-110.79%	-149.5%	-600.54%
FREE CASH FLOW
Cash From Operating Activities	$61.94M	$73.34M	$274.7M
Capital Expenditures	$568.0K	$164.0K	$461.0K
Free Cash Flow	$61.37M	$73.17M	$274.3M
YoY Change	123.2%	11.91%	123.71%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2023#ProductMember
CY2022	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2023#ProductMember
CY2023	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2023#ProductMember
CY2021	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://fasb.org/us-gaap/2023#ProductMember
CY2022	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://fasb.org/us-gaap/2023#ProductMember
CY2023	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://fasb.org/us-gaap/2023#ProductMember
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2022Q4	coll	Fair Value Assets Level2 To Level1 Transfers Amount1 FairValueAssetsLevel2ToLevel1TransfersAmount1	0
CY2023Q4	coll	Fair Value Assets Level2 To Level1 Transfers Amount1 FairValueAssetsLevel2ToLevel1TransfersAmount1	0
CY2022Q4	coll	Fair Value Liabilities Level1 To Level2 Transfers Amount1 FairValueLiabilitiesLevel1ToLevel2TransfersAmount1	0
CY2023Q4	coll	Fair Value Liabilities Level1 To Level2 Transfers Amount1 FairValueLiabilitiesLevel1ToLevel2TransfersAmount1	0
CY2022Q4	coll	Fair Value Liabilities Level2 To Level1 Transfers Amount1 FairValueLiabilitiesLevel2ToLevel1TransfersAmount1	0
CY2023Q4	coll	Fair Value Liabilities Level2 To Level1 Transfers Amount1 FairValueLiabilitiesLevel2ToLevel1TransfersAmount1	0
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001267565
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q4	us-gaap	Fair Value Disclosure Offbalance Sheet Risks Amount Liability FairValueDisclosureOffbalanceSheetRisksAmountLiability	0
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	0
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	0
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-37372
CY2023	dei	Entity Registrant Name EntityRegistrantName	Collegium Pharmaceutical, Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	VA
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	03-0416362
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	100 Technology Center Drive
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Stoughton
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02072
CY2023	dei	City Area Code CityAreaCode	781
CY2023	dei	Local Phone Number LocalPhoneNumber	713-3699
CY2023	dei	Security12b Title Security12bTitle	Common stock
CY2023	dei	Trading Symbol TradingSymbol	COLL
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	741800000
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	31959828
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	coll	Rule10b51 Arrangement Amended Rule10b51ArrangementAmended	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	coll	Non Rule10b51 Arrangement Amended NonRule10b51ArrangementAmended	false
CY2023	dei	Auditor Firm AuditorFirmId	34
CY2023	dei	Auditor Name AuditorName	Deloitte & Touche LLP
CY2023	dei	Auditor Location AuditorLocation	Boston, Massachusetts
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	238947000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	173688000
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	71601000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	179525000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	183119000
CY2023Q4	us-gaap	Inventory Net InventoryNet	32332000
CY2022Q4	us-gaap	Inventory Net InventoryNet	46501000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	15195000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16681000
CY2023Q4	us-gaap	Assets Current AssetsCurrent	537600000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	419989000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15983000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	19521000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6029000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6861000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	421708000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	567468000
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1047000
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	2547000
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	26259000
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	23950000
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	825000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	100000
CY2023Q4	us-gaap	Goodwill Goodwill	133857000
CY2022Q4	us-gaap	Goodwill Goodwill	133695000
CY2023Q4	us-gaap	Assets Assets	1143308000
CY2022Q4	us-gaap	Assets Assets	1174131000
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8692000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3494000
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	37571000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	36129000
CY2023Q4	coll	Accrued Rebates Returns And Discounts Current AccruedRebatesReturnsAndDiscountsCurrent	227331000
CY2022Q4	coll	Accrued Rebates Returns And Discounts Current AccruedRebatesReturnsAndDiscountsCurrent	230491000
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent	183333000
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	162500000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	988000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1112000
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	457915000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	433726000
CY2023Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	221713000
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	397578000
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	262125000
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	140873000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6124000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7112000
CY2023Q4	us-gaap	Liabilities Liabilities	947877000
CY2022Q4	us-gaap	Liabilities Liabilities	979289000
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38192441
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31868549
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37084759
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33848936
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	38000
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	37000
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	565949000
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	538073000
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	6323892
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	3235823
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	137381000
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	61924000
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	14000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-233189000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-281344000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	195431000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	194842000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1143308000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1174131000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	566767000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	463933000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	276868000
CY2023	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	94838000
CY2022	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	118190000
CY2021	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	59070000
CY2023	coll	Amortization And Impairment Of Intangible Assets AmortizationAndImpairmentOfIntangibleAssets	145760000
CY2022	coll	Amortization And Impairment Of Intangible Assets AmortizationAndImpairmentOfIntangibleAssets	136255000
CY2021	coll	Amortization And Impairment Of Intangible Assets AmortizationAndImpairmentOfIntangibleAssets	67181000
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	240598000
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	254445000
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	126251000
CY2023	us-gaap	Gross Profit GrossProfit	326169000
CY2022	us-gaap	Gross Profit GrossProfit	209488000
CY2021	us-gaap	Gross Profit GrossProfit	150617000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3983000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9451000
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	159208000
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	172186000
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	118960000
CY2021	us-gaap	Restructuring Charges RestructuringCharges	4578000
CY2023	us-gaap	Operating Expenses OperatingExpenses	159208000
CY2022	us-gaap	Operating Expenses OperatingExpenses	176169000
CY2021	us-gaap	Operating Expenses OperatingExpenses	132989000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	166961000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	33319000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	17628000
CY2023	us-gaap	Interest Expense InterestExpense	83339000
CY2022	us-gaap	Interest Expense InterestExpense	63213000
CY2021	us-gaap	Interest Expense InterestExpense	21014000
CY2023	us-gaap	Investment Income Net InvestmentIncomeNet	15615000
CY2022	us-gaap	Investment Income Net InvestmentIncomeNet	1047000
CY2021	us-gaap	Investment Income Net InvestmentIncomeNet	12000
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-23504000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	75733000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-28847000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3374000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	27578000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3845000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-74891000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	48155000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-25002000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	71517000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.43
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.74
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.05
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33741213
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33829495
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34936817
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.29
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.74
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.86
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41788125
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33829495
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41045805
CY2023	us-gaap	Net Income Loss NetIncomeLoss	48155000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-25002000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	71517000
CY2023	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	14000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	14000
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	48169000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-25002000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	71517000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	186031000
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	11869000
CY2021	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	755000
CY2021	coll	Stock Withheld For Employee Taxes Upon Vesting Of Restricted Stock Units Value StockWithheldForEmployeeTaxesUponVestingOfRestrictedStockUnitsValue	-4149000
CY2021	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	42861000
CY2021	coll	Adjustments To Additional Paid In Capital Forward Contract On Share Repurchase Agreement AdjustmentsToAdditionalPaidInCapitalForwardContractOnShareRepurchaseAgreement	5000000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	24255000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	71517000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	202928000
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	11811000
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	337000
CY2022	coll	Stock Vested During Period Value Restricted Stock Units StockVestedDuringPeriodValueRestrictedStockUnits	1000
CY2022	coll	Stock Withheld For Employee Taxes Upon Vesting Of Restricted Stock Units Value StockWithheldForEmployeeTaxesUponVestingOfRestrictedStockUnitsValue	-4044000
CY2022	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	14063000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	22874000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-25002000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	194842000
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	8641000
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	460000
CY2023	coll	Stock Vested During Period Value Restricted Stock Units StockVestedDuringPeriodValueRestrictedStockUnits	1000
CY2023	coll	Stock Withheld For Employee Taxes Upon Vesting Of Restricted Stock Units Value StockWithheldForEmployeeTaxesUponVestingOfRestrictedStockUnitsValue	-8361000
CY2023	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	75457000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	27136000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	14000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	48155000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	195431000
CY2023	us-gaap	Profit Loss ProfitLoss	48155000
CY2022	us-gaap	Profit Loss ProfitLoss	-25002000
CY2021	us-gaap	Profit Loss ProfitLoss	71517000
CY2023	coll	Amortization And Impairment Of Intangible Assets AmortizationAndImpairmentOfIntangibleAssets	145760000
CY2022	coll	Amortization And Impairment Of Intangible Assets AmortizationAndImpairmentOfIntangibleAssets	136255000
CY2021	coll	Amortization And Impairment Of Intangible Assets AmortizationAndImpairmentOfIntangibleAssets	67181000
CY2023	us-gaap	Depreciation Depreciation	3496000
CY2022	us-gaap	Depreciation Depreciation	2684000
CY2021	us-gaap	Depreciation Depreciation	1736000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2153000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-8391000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-78042000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	27136000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	22874000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	24255000
CY2023	coll	Operating Lease Payments Non Cash OperatingLeasePaymentsNonCash	-280000
CY2022	coll	Operating Lease Payments Non Cash OperatingLeasePaymentsNonCash	238000
CY2021	coll	Operating Lease Payments Non Cash OperatingLeasePaymentsNonCash	18000
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-23504000
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	8635000
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	8285000
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	3406000
CY2023	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	1235000
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3594000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	21780000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	22524000
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-14169000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-48274000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2296000
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1439000
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4606000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1086000
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	5061000
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-707000
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-5827000
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	628000
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-11131000
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	4777000
CY2023	coll	Increase Decrease In Accrued Rebates Returns And Discounts IncreaseDecreaseInAccruedRebatesReturnsAndDiscounts	-3160000
CY2022	coll	Increase Decrease In Accrued Rebates Returns And Discounts IncreaseDecreaseInAccruedRebatesReturnsAndDiscounts	-22766000
CY2021	coll	Increase Decrease In Accrued Rebates Returns And Discounts IncreaseDecreaseInAccruedRebatesReturnsAndDiscounts	40442000
CY2022	coll	Increase Decrease In Operating Lease Asset And Liabilities IncreaseDecreaseInOperatingLeaseAssetAndLiabilities	3000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	274749000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	124230000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	103557000
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	461000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1622000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1944000
CY2023	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	92351000
CY2023	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	22000000
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	572069000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-70812000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-573691000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1944000
CY2023	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	460000
CY2022	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	337000
CY2021	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	755000
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8641000
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	11811000
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	11952000
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	8361000
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	4044000
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	4149000
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	75000000
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	14063000
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	47861000
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	162500000
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	75000000
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	50000000
CY2022	coll	Proceeds From Term Note Modification ProceedsFromTermNoteModification	517682000
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	6280000
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	235220000
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	138638000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-140178000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	436723000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-89303000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	63759000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-12738000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	12310000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	176235000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	188973000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	176663000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	239994000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	176235000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	188973000
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	238947000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	173688000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	186426000
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	24205000
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1047000
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	2547000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	2547000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	239994000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	176235000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	188973000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	73256000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	52528000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	17608000
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	10400000
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3005000
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	176000
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	72000
CY2023	coll	Share Repurchase Program Excise Tax Included In Accrued Liabilities ShareRepurchaseProgramExciseTaxIncludedInAccruedLiabilities	457000
CY2021	coll	Inventory Used In Construction And Installation Of Property And Equipment InventoryUsedInConstructionAndInstallationOfPropertyAndEquipment	516000
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Use of Estimates</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The preparation of the consolidated financial statements in accordance with GAAP requires the Company to make estimates and assumptions that impact the reported amounts of assets, liabilities, revenues, costs and expenses and the disclosure of contingent assets and liabilities in the Company’s consolidated financial statements and accompanying notes. Estimates in the Company’s consolidated financial statements include revenue recognition, including the estimates of product returns, discounts and allowances related to commercial sales of products, estimates related to the fair value of assets acquired and liabilities assumed, including acquired intangible assets and the fair value of inventory acquired, estimates utilized in the ongoing valuation of inventory related to potential unsalable product, estimates of useful lives with respect to intangible assets, accounting for stock-based compensation, contingencies, impairment of intangible assets and deferred tax valuation allowances. The Company bases estimates and assumptions on historical experience when available and on various factors that it believes to be reasonable under the circumstances. The Company evaluates its estimates and assumptions on an ongoing basis. The Company’s actual results may differ from these estimates under different assumptions or conditions.</p>
CY2022Q4	coll	Fair Value Assets Level1 To Level2 Transfers Amount1 FairValueAssetsLevel1ToLevel2TransfersAmount1	0
CY2023Q4	coll	Fair Value Assets Level1 To Level2 Transfers Amount1 FairValueAssetsLevel1ToLevel2TransfersAmount1	0
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	153629000
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	172590000
CY2023	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	54044000
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Concentration of Credit Risk</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Financial instruments, which potentially subject the Company to significant concentration of credit risk, consist primarily of cash and cash equivalents and accounts receivable. The Company maintains its cash deposits primarily with one reputable and nationally recognized financial institution. In addition, as of December 31, 2023, the Company’s cash equivalents were invested in money market funds. The Company has not experienced any material losses in such accounts and management believes that the Company is not exposed to significant credit risk due to the financial position of the financial institutions in which those deposits are held and the nature of the assets in the money market funds. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Three customers comprised 10% or more of the Company’s accounts receivable balance as of December 31, 2023. These customers comprised 38%, 35%, and 26% of the accounts receivable balance as of December 31, 2023 and 37%, 33%, and 28% as of December 31, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The same customers comprised 10% or more of the Company’s revenue during the year ended December 31, 2023. These customers comprised 33%, 32%, and 32% of revenue during the year ended December 31, 2023; 33%, 32%, and 31% during the year ended December 31, 2022; and 35%, 31%, and 29% during the year ended December 31, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">To date, the Company has not experienced any credit losses with respect to the collection of its accounts receivable and has not recorded an allowance for credit losses as of December 31, 2023 or 2022. The Company has no financial instruments with <span style="-sec-ix-hidden:Hidden_nal7sPzUVEeD5Z8L1MgJ2Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">off</span></span> balance sheet risk of loss.</p>
CY2023	coll	Concentration Of Credit Risk Number Of Financial Institution ConcentrationOfCreditRiskNumberOfFinancialInstitution	1
CY2023Q4	us-gaap	Fair Value Disclosure Offbalance Sheet Risks Amount Asset FairValueDisclosureOffbalanceSheetRisksAmountAsset	0
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0
CY2021Q4	us-gaap	Restructuring Charges RestructuringCharges	4578000
CY2021Q4	us-gaap	Payments For Restructuring PaymentsForRestructuring	1335000
	us-gaap	Payments For Restructuring PaymentsForRestructuring	3243000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	463933000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	276868000
CY2022	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-25002000
CY2021	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	76192000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33741213
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33829495
CY2023Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0
CY2023	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0
CY2023	us-gaap	Derivatives Embedded Derivatives DerivativesEmbeddedDerivatives	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><b style="font-weight:bold;">Embedded Derivatives</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><span style="font-weight:bold;visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;">The Company accounts for derivative financial instruments as either equity or liabilities in accordance with Accounting Standards Codification Topic 815, <i style="font-style:italic;">Derivatives and Hedging</i>, (“ASC 815”) based on the characteristics and provisions of each instrument. Embedded derivatives are required to be bifurcated from the host instruments and recorded at fair value if the derivatives are not clearly and closely related to the host instruments on the date of issuance. The Company’s term notes and convertible notes (refer to Note 14, <i style="font-style:italic;">Debt</i>) contain certain features that, in accordance with ASC 815, are not clearly and closely related to the host instrument and represent derivatives that are required to be re-measured at fair value each reporting period. The Company determined that the estimated fair value of the derivatives at issuance and through December 31, 2023 were not material based on a scenario-based cash flow model that uses unobservable inputs that reflect the Company’s own assumptions. Should the Company’s assessment of the probabilities around these scenarios change, including due to changes in market conditions, there could be a change to the fair value.</p>
CY2023	us-gaap	Revenue Practical Expedient Incremental Cost Of Obtaining Contract RevenuePracticalExpedientIncrementalCostOfObtainingContract	true
CY2023	coll	Returns Policy Threshold Product Return Period ReturnsPolicyThresholdProductReturnPeriod	P18M
CY2023	coll	Returns Policy Threshold Product Return Period Prior To Expiration ReturnsPolicyThresholdProductReturnPeriodPriorToExpiration	P6M
CY2023	coll	Returns Policy Threshold Product Return Period After Expiration ReturnsPolicyThresholdProductReturnPeriodAfterExpiration	P12M
CY2021	coll	Maximum Percentage Of Actual Return To Returns Claimed MaximumPercentageOfActualReturnToReturnsClaimed	0.20
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	566767000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	48155000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-25002000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	71517000
CY2023	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	5889000
CY2021	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	4675000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34936817
CY2021	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	131257
CY2023	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	6793421
CY2021	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	4925134
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41788125
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33829495
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41045805
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.43
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.74
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.05
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.29
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.74
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.86
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	76330000
CY2023Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	76316000
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	59000
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	45000
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	76330000
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	61672000
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	14658000
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	76330000
CY2023	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	10384000
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	5600000
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	6740000
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	24672000
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	15208000
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	16229000
CY2023Q4	us-gaap	Inventory Net InventoryNet	32332000
CY2022Q4	us-gaap	Inventory Net InventoryNet	46501000
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	5938000
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	5614000
CY2023Q4	us-gaap	Prepaid Taxes PrepaidTaxes	1416000
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	5138000
CY2023Q4	coll	Prepaid Savings Vouchers PrepaidSavingsVouchers	1758000
CY2022Q4	coll	Prepaid Savings Vouchers PrepaidSavingsVouchers	1907000
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	672000
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	960000
CY2023Q4	us-gaap	Retainage Deposit RetainageDeposit	2640000
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	93000
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	57000
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	2678000
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	3005000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	15195000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16681000
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	25661000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	25844000
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9678000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6323000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15983000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	19521000
CY2023	us-gaap	Depreciation Depreciation	3496000
CY2022	us-gaap	Depreciation Depreciation	2684000
CY2021	us-gaap	Depreciation Depreciation	1736000
CY2023	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	141000
CY2022	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	1040000
CY2021	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	96000
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	133695000
CY2022Q4	us-gaap	Goodwill Goodwill	133695000
CY2023	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	162000
CY2023Q4	us-gaap	Goodwill Goodwill	133857000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	951170000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	529462000
CY2022Q4	coll	Accrued Product Taxes And Fees Current AccruedProductTaxesAndFeesCurrent	4352000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	421708000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	956170000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	388702000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	567468000
CY2023	coll	Amortization And Impairment Of Intangible Assets AmortizationAndImpairmentOfIntangibleAssets	145760000
CY2022	coll	Amortization And Impairment Of Intangible Assets AmortizationAndImpairmentOfIntangibleAssets	136255000
CY2021	coll	Amortization And Impairment Of Intangible Assets AmortizationAndImpairmentOfIntangibleAssets	67181000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	138062000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	138062000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	110370000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	7285000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	7285000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	20644000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	421708000
CY2023Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	14198000
CY2022Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	13770000
CY2023Q4	coll	Accrued Product Taxes And Fees Current AccruedProductTaxesAndFeesCurrent	5013000
CY2023Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	4987000
CY2022Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	6347000
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	2853000
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1410000
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2136000
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1511000
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1208000
CY2023Q4	coll	Accrued Incentive Compensation Current AccruedIncentiveCompensationCurrent	1375000
CY2022Q4	coll	Accrued Incentive Compensation Current AccruedIncentiveCompensationCurrent	1507000
CY2023Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	1198000
CY2022Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	2130000
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	700000
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1957000
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3600000
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3448000
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	37571000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	36129000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6029000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	7112000
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	1306000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	1805000
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	1305000
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1446000
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	993000
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1492000
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	565000
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	331000
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	292000
CY2023	us-gaap	Lease Cost LeaseCost	3317000
CY2022	us-gaap	Lease Cost LeaseCost	3129000
CY2021	us-gaap	Lease Cost LeaseCost	3089000
CY2023	coll	Schedule Of Lease Quantitative Details ScheduleOfLeaseQuantitativeDetails	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td colspan="5" style="vertical-align:middle;width:22.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Years Ended December 31,</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td colspan="2" style="vertical-align:middle;width:11.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td colspan="2" style="vertical-align:middle;width:8.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Weighted-average remaining lease term — operating leases (years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5.7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6.6</p></td></tr><tr><td style="vertical-align:bottom;width:74.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Weighted-average discount rate — operating leases</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">6.2%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">6.2%</p></td></tr></table>
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y8M12D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y7M6D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.062
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.062
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	1585000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	1568000
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	1286000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1398000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1436000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1474000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1489000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1527000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1169000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	8493000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1381000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	7112000
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	21504000
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	166000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.007
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.672
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	12.60
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	4786000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	3943000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	6456000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	2244157
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	27136000
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	22874000
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	24255000
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	8227000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	4540000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3142000
CY2023	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	29731000
CY2022	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	4706000
CY2021	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	3142000
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1401000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-4631000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-61445000
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-752000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-3920000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-16588000
CY2023	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-2153000
CY2022	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-8551000
CY2021	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-78033000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	27578000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3845000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-74891000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.049
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.050
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.029
CY2023	coll	Effective Income Tax Rate Reconciliation Nondeductible Expense Debt Extinguishment EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDebtExtinguishment	0.071
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.013
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.019
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.039
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.010
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.051
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.188
CY2022	coll	Effective Income Tax Rate Reconciliation Research And Development Credit EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentCredit	0.007
CY2021	coll	Effective Income Tax Rate Reconciliation Research And Development Credit EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentCredit	0.163
CY2022	coll	Effective Income Tax Rate Reconciliation Transaction Costs Percent EffectiveIncomeTaxRateReconciliationTransactionCostsPercent	-0.044
CY2023	coll	Effective Income Tax Rate Reconciliation Change In Tax Rates And Other Percent EffectiveIncomeTaxRateReconciliationChangeInTaxRatesAndOtherPercent	0.004
CY2022	coll	Effective Income Tax Rate Reconciliation Change In Tax Rates And Other Percent EffectiveIncomeTaxRateReconciliationChangeInTaxRatesAndOtherPercent	-0.020
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.007
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	22.025
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.364
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.133
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	22.200
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	33800000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	56982000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	1769000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	5036000
CY2023Q4	coll	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	1803000
CY2022Q4	coll	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	2131000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances	18528000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances	19423000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	7570000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6776000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	6257000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	5228000
CY2022Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	3647000
CY2023Q4	coll	Deferred Tax Assets Capitalized Research And Development DeferredTaxAssetsCapitalizedResearchAndDevelopment	707000
CY2022Q4	coll	Deferred Tax Assets Capitalized Research And Development DeferredTaxAssetsCapitalizedResearchAndDevelopment	929000
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	32771000
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	23592000
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	103205000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	123744000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5781000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5254000
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	97424000
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	118490000
CY2023Q4	coll	Deferred Tax Liabilities Debt Discount DeferredTaxLiabilitiesDebtDiscount	344000
CY2022Q4	coll	Deferred Tax Liabilities Debt Discount DeferredTaxLiabilitiesDebtDiscount	406000
CY2023Q4	coll	Deferred Tax Liabilities Operating Lease Assets DeferredTaxLiabilitiesOperatingLeaseAssets	1529000
CY2022Q4	coll	Deferred Tax Liabilities Operating Lease Assets DeferredTaxLiabilitiesOperatingLeaseAssets	1778000
CY2022Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts	3918000
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	65774000
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	84167000
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	3518000
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	4271000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	71165000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	94540000
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	26259000
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	23950000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5781000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5254000
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	527000
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	78042000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	11400000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	654000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	586000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	67000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	10930000
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	94000
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	184000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	1000
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	11306000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	11400000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	654000
CY2023Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	11275000
CY2022Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	11368000
CY2021Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	500000
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1759000
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1315000
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1236000
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	144767000
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	135546000
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	136709000
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	149745000
CY2023Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	29899000
CY2023Q2	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	24257000
CY2023Q3	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	20081000
CY2023Q4	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	20601000
CY2023Q1	coll	Amortization And Impairment Of Intangible Assets AmortizationAndImpairmentOfIntangibleAssets	37466000
CY2023Q2	coll	Amortization And Impairment Of Intangible Assets AmortizationAndImpairmentOfIntangibleAssets	37463000
CY2023Q3	coll	Amortization And Impairment Of Intangible Assets AmortizationAndImpairmentOfIntangibleAssets	36317000
CY2023Q4	coll	Amortization And Impairment Of Intangible Assets AmortizationAndImpairmentOfIntangibleAssets	34514000
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	67365000
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	61720000
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	56398000
CY2023Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	55115000
CY2023Q1	us-gaap	Gross Profit GrossProfit	77402000
CY2023Q2	us-gaap	Gross Profit GrossProfit	73826000
CY2023Q3	us-gaap	Gross Profit GrossProfit	80311000
CY2023Q4	us-gaap	Gross Profit GrossProfit	94630000
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	52775000
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	38193000
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	35298000
CY2023Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	32942000
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	52775000
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	38193000
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	35298000
CY2023Q4	us-gaap	Operating Expenses OperatingExpenses	32942000
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	24627000
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	35633000
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	45013000
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	61688000
CY2023Q1	us-gaap	Interest Expense InterestExpense	21427000
CY2023Q2	us-gaap	Interest Expense InterestExpense	21863000
CY2023Q3	us-gaap	Interest Expense InterestExpense	20768000
CY2023Q4	us-gaap	Interest Expense InterestExpense	19281000
CY2023Q1	us-gaap	Investment Income Net InvestmentIncomeNet	2747000
CY2023Q2	us-gaap	Investment Income Net InvestmentIncomeNet	4027000
CY2023Q3	us-gaap	Investment Income Net InvestmentIncomeNet	4538000
CY2023Q4	us-gaap	Investment Income Net InvestmentIncomeNet	4303000
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-23504000
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17557000
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	17797000
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	28783000
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	46710000
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-131000
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4790000
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8149000
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14770000
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-17426000
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	13007000
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	20634000
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	31940000
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.51
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.38
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.61
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.99
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34319291
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34622284
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33744209
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32301211
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.51
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.34
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.53
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.82
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34319291
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42849952
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42058821
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41279981
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	83751000
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	123549000
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	127013000
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	129620000
CY2022Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	16332000
CY2022Q2	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	33684000
CY2022Q3	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	30622000
CY2022Q4	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	37552000
CY2022Q1	coll	Amortization And Impairment Of Intangible Assets AmortizationAndImpairmentOfIntangibleAssets	18923000
CY2022Q2	coll	Amortization And Impairment Of Intangible Assets AmortizationAndImpairmentOfIntangibleAssets	37501000
CY2022Q3	coll	Amortization And Impairment Of Intangible Assets AmortizationAndImpairmentOfIntangibleAssets	37552000
CY2022Q4	coll	Amortization And Impairment Of Intangible Assets AmortizationAndImpairmentOfIntangibleAssets	42279000
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	35255000
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	71185000
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	68174000
CY2022Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	79831000
CY2022Q1	us-gaap	Gross Profit GrossProfit	48496000
CY2022Q2	us-gaap	Gross Profit GrossProfit	52364000
CY2022Q3	us-gaap	Gross Profit GrossProfit	58839000
CY2022Q4	us-gaap	Gross Profit GrossProfit	49789000
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3983000
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	54528000
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	41254000
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	38372000
CY2022Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	38032000
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	58511000
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	41254000
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	38372000
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	38032000
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-10015000
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	11110000
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	20467000
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	11757000
CY2022Q1	us-gaap	Interest Expense InterestExpense	5831000
CY2022Q2	us-gaap	Interest Expense InterestExpense	17761000
CY2022Q3	us-gaap	Interest Expense InterestExpense	19046000
CY2022Q4	us-gaap	Interest Expense InterestExpense	20575000
CY2022Q1	us-gaap	Investment Income Net InvestmentIncomeNet	4000
CY2022Q2	us-gaap	Investment Income Net InvestmentIncomeNet	5000
CY2022Q3	us-gaap	Investment Income Net InvestmentIncomeNet	11000
CY2022Q4	us-gaap	Investment Income Net InvestmentIncomeNet	1027000
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15842000
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6646000
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1432000
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7791000
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2773000
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1455000
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	975000
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-592000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-13069000
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-5191000
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	457000
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-7199000
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.39
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33673912
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34001553
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34058802
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33582202
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.39
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33673912
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34001553
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34570319
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33582202

Files In Submission

Name	View Source	Status
0001558370-24-001526-index-headers.html	Edgar Link	pending
0001558370-24-001526-index.html	Edgar Link	pending
0001558370-24-001526.txt	Edgar Link	pending
0001558370-24-001526-xbrl.zip	Edgar Link	pending
coll-20231231.xsd	Edgar Link	pending
coll-20231231x10k.htm	Edgar Link	pending
coll-20231231x10k001.jpg	Edgar Link	pending
coll-20231231x10k003.jpg	Edgar Link	pending
coll-20231231xex10d14.htm	Edgar Link	pending
coll-20231231xex10d4.htm	Edgar Link	pending
coll-20231231xex10d4001.jpg	Edgar Link	pending
coll-20231231xex19.htm	Edgar Link	pending
coll-20231231xex19001.jpg	Edgar Link	pending
coll-20231231xex21d1.htm	Edgar Link	pending
coll-20231231xex23d1.htm	Edgar Link	pending
coll-20231231xex31d1.htm	Edgar Link	pending
coll-20231231xex31d2.htm	Edgar Link	pending
coll-20231231xex32d1.htm	Edgar Link	pending
coll-20231231xex32d2.htm	Edgar Link	pending
coll-20231231x10k_htm.xml	Edgar Link	completed
coll-20231231xex97.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
coll-20231231_lab.xml	Edgar Link	unprocessable
coll-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
coll-20231231_cal.xml	Edgar Link	unprocessable
coll-20231231_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$COLL
COLLEGIUM PHARMACEUTICAL, INC Stock $coll

2024 Q1 Form 10-K Financial Statement

#000155837024001526 Filed on February 22, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$COLL COLLEGIUM PHARMACEUTICAL, INC Stock $coll

2024 Q1 Form 10-K Financial Statement

#000155837024001526 Filed on February 22, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$COLL
COLLEGIUM PHARMACEUTICAL, INC Stock $coll